Bristol-Myers Squibb Company is a major biopharmaceutical company based in New Jersey. According to its filings, it lobbies on health care matters, especially policies affecting biosimilars (generic versions of biologic drugs), reimbursement and supply chain rules, and payment reforms for Medicare and Medicaid. It reported about $30,000 in lobbying across three filings and used Miller Strategies, LLC.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ASHLEY GUNN
The latest disclosures for this client.
MILLER STRATEGIES, LLC
Q1MILLER STRATEGIES, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MILLER STRATEGIES, LLC
JEFFREY MILLER
MILLER STRATEGIES, LLC
MILLER STRATEGIES, LLC
Q3MILLER STRATEGIES, LLC
RR